Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Modulating immune cell fate and inflammation through CRISPR-mediated DNA methylation editing [DNA methylation arrays]

ABSTRACT: We assessed both on-target and off-target DNA methylation editing events following targeting with dCas9-DNMT3A to the IL1RN locus in cells undergoing B to macrophage transdifferentiation.

ORGANISM(S): Homo sapiens

PROVIDER: GSE268284 | GEO | 2025/06/02

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Modulating immune cell fate and inflammation through CRISPR-mediated DNA methylation editing [dCas9-DNMT3A ChIP-seq]

Project description:To investigate the genome-wide occupancy of the DNA methylation editing tool dCas9-DNMT3A in cells harboring non-targeting sgRNAs (CTRL) and cells harboring sgRNAs targeting the IL1RN promoter (sgIL1RN).

2025-06-02 | GSE270885 | GEO

Modulating immune cell fate and inflammation through CRISPR-mediated DNA methylation editing [RNA-seq, transdifferentiation]

Project description:We examine the differential transcriptional dynamics during the C/EBPa-driven transdifferentiation of B-cells into iMacs in cells with experimentally induced hypermethylation of the IL1RN gene promoter.

2025-06-02 | GSE270876 | GEO

Editing DNA methylation in the mammalian genome

Project description:Mammalian DNA methylation is a critical epigenetic mechanism orchestrating gene expression networks in many biological processes. However, investigation of the functions of specific methylation events remains challenging. Here, we demonstrate that fusion of Tet1 or Dnmt3a with a catalytically inactive Cas9 (dCas9) enables targeted DNA methylation editing. Targeting of the dCas9-Tet1 or -Dnmt3a fusion protein to methylated or unmethylated promoter sequences caused activation or silencing, respectively, of an endogenous reporter. Targeted demethylation of the BDNF promoter IV or the MyoD distal enhancer by dCas9-Tet1 induced BDNF expression in post-mitotic neurons or activated MyoD facilitating reprogramming of fibroblasts into myoblasts, respectively. Targeted de novo methylation of a CTCF loop anchor site by dCas9-Dnmt3a blocked CTCF binding and interfered with DNA looping, causing altered gene expression in the neighboring loop. Finally, we show that these tools can edit DNA methylation in mice demonstrating their wide utility for functional studies of epigenetic regulation.

2016-09-23 | GSE83890 | GEO

DNA epigenome editing using CRISPR-Cas SunTag-directed DNMT3A [WGBS]

Project description:We demonstrate that dCas9-SunTag-DNMT3A dramatically increased CpG methylation at the HOXA5 locus in human embryonic kidney 293T cells (HEK293T). Furthermore, using a single sgRNA, dCas9-SunTag-DNMT3A was able to methylate a 4.5 kb genomic region and repress HOXA5 gene expression. Reduced representation bisulfite sequencing (RRBS) and RNA-seq showed that dCas9-SunTag-DNMT3A methylated regions of interest with minimal impact on the global DNA methylome and transcriptome.

2017-08-22 | GSE97814 | GEO

DNA epigenome editing using CRISPR-Cas SunTag-directed DNMT3A [RRBS]

2017-08-22 | GSE97813 | GEO

DNA epigenome editing using CRISPR-Cas SunTag-directed DNMT3A [RNA-Seq]

2017-08-22 | GSE97815 | GEO

DNA epigenome editing using CRISPR-Cas SunTag-directed DNMT3A [BS-Seq]

Project description:Here, we demonstrate that dCas9-SunTag-DNMT3A dramatically increased CpG methylation at the HOXA5 locus in human embryonic kidney 293T cells (HEK293T). Furthermore, using a single sgRNA, dCas9-SunTag-DNMT3A was able to methylate a 4.5 kb genomic region and repress HOXA5 gene expression. Reduced representation bisulfite sequencing (RRBS) and RNA-seq showed that dCas9-SunTag-DNMT3A methylated regions of interest with minimal impact on the global DNA methylome and transcriptome.

2017-08-22 | GSE97812 | GEO

Modulating immune cell fate and inflammation through CRISPR-mediated DNA methylation editing [RNA-seq, IL1B treatment]

Project description:We analyzed the differential transcriptional response to IL-1β treatment in cells with experimentally induced hypermethylation of the IL1RN gene promoter.

2025-06-02 | GSE270873 | GEO

Engineering epigenetic memory requires co-targeting of histone methylatransferases and DNA methylatransferases [Methylation]

Project description:Rewriting of the epigenome has risen as a promising alternative to gene editing for precision medicine. In nature, epigenetic silencing can result in complete attenuation of target gene expression over multiple mitotic divisions. However, persistent repression has been difficult to achieve using targeted systems. Here, we report that robust and persistent epigenetic memory required both a DNA methyltransferase (DNMT3A-dCas9) and a histone methyltransferase (Ezh2-dCas9 or KRAB-dCas9). DNMT3A-dCas9 was dependent on full-length DNMT3L for maximal activity. Co-targeting with Ezh2-dCas9, DNMT3A-dCas9 and DNMT3L induced long-term HER2 repression over at least 50 days and maintained a heterochromatic environment. Interestingly, substitution of Ezh2-dCas9 for KRAB-dCas9 enabled long-term repression at some target genes (e.g., SNURF) but not at HER2, at which H3K9me3 and DNA methylation were transiently acquired and subsequently lost. Off-target DNA hypermethylation occurred at many individual CpG sites but rarely at multiple CpGs in a single promoter, consistent with no detectable effect on transcription at the loci tested. Conversely, robust hypermethylation was observed at HER2. These data demonstrate that targeting different combinations of histone and DNA methyltransferases is required to achieve maximal repression at different loci in the same cell, or the same locus in different cells.

2019-05-07 | GSE123830 | GEO

Modulating immune cell fate and inflammation through CRISPR-mediated DNA methylation editing [WGBS-seq]

Project description:We investigated the genome-wide DNA methylation dynamics occurring during the C/EBPa-driven B cell to macrophage transdifferentiation.

2025-06-02 | GSE270886 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data